• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MMP9 和 STAT1 是抗结核治疗后免疫浸润变化的生物标志物,免疫状态可以识别脊柱结核患者。

MMP9 and STAT1 are biomarkers of the change in immune infiltration after anti-tuberculosis therapy, and the immune status can identify patients with spinal tuberculosis.

机构信息

Department of Spine and Osteopathy Ward, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China.

出版信息

Int Immunopharmacol. 2023 Mar;116:109588. doi: 10.1016/j.intimp.2022.109588. Epub 2023 Feb 9.

DOI:10.1016/j.intimp.2022.109588
PMID:36773569
Abstract

BACKGROUND

Due to a lack of studies on immune-related pathogenesis and a clinical diagnostic model, the diagnosis of Spinal Tuberculosis (STB) remains uncertain. Our study aimed to investigate the possible pathogenesis of STB and to develop a clinical diagnostic model for STB based on immune cell infiltration.

METHODS

Label-free quantification protein analysis of five pairs of specimens was used to determine the protein expression of the intervertebral disc in STB and non-STB. GO enrichment analysis, and KEGG pathway analysis were used to investigate the pathogenesis of STB. The Hub proteins were then eliminated. Four datasets were downloaded from the GEO database to analyze immune cell infiltration, and the results were validated using blood routine test data from 8535TB and 7337 non-TB patients. Following that, clinical data from 164 STB and 162 non-STB patients were collected. The Random-Forest algorithm was used to screen out clinical predictors of STB and build a diagnostic model. The differential expression of MMP9 and STAT1 in STB and controls was confirmed using immunohistochemistry.

RESULTS

MMP9 and STAT1 were STB Hub proteins that were linked to disc destruction in STB. MMP9 and STAT1 were found to be associated with Monocytes, Neutrophils, and Lymphocytes in immune cell infiltration studies. Data from 15,872 blood routine tests revealed that the Monocytes ratio and Neutrophils ratio was significantly higher in TB patients than in non-TB patients (p < 0.001), while the Lymphocytes ratio was significantly lower in TB patients than in non-TB patients (p < 0.001). MMP9 and STAT1 expression were downregulated following the anti-TB therapy. For STB, a clinical diagnostic model was built using six clinical predictors: MR, NR, LR, ESR, BMI, and PLT. The model was evaluated using a ROC curve, which yielded an AUC of 0.816.

CONCLUSIONS

MMP9 and STAT1, immune-related hub proteins, were correlated with immune cell infiltration in STB patients. MR, NR, LR ESR, BMI, and PLT were clinical predictors of STB. Thus, the immune cell Infiltration-related clinical diagnostic model can predict STB effectively.

摘要

背景

由于缺乏对免疫相关发病机制的研究和临床诊断模型,脊柱结核(STB)的诊断仍不确定。本研究旨在探讨 STB 的可能发病机制,并基于免疫细胞浸润建立 STB 的临床诊断模型。

方法

采用无标记定量蛋白质分析技术对 5 对 STB 和非 STB 椎间盘标本进行检测,确定 STB 椎间盘的蛋白表达。采用 GO 富集分析和 KEGG 通路分析探讨 STB 的发病机制。然后消除枢纽蛋白。从 GEO 数据库下载了 4 个数据集,分析免疫细胞浸润情况,并使用 8535 例 TB 和 7337 例非 TB 患者的血常规检测数据进行验证。随后收集了 164 例 STB 和 162 例非 STB 患者的临床资料。采用随机森林算法筛选 STB 的临床预测指标,并建立诊断模型。采用免疫组化法验证 MMP9 和 STAT1 在 STB 及对照组中的差异表达。

结果

MMP9 和 STAT1 是 STB 的枢纽蛋白,与 STB 中的椎间盘破坏有关。在免疫细胞浸润研究中,发现 MMP9 和 STAT1 与单核细胞、中性粒细胞和淋巴细胞有关。15872 例血常规检测数据显示,TB 患者的单核细胞比和中性粒细胞比显著高于非 TB 患者(p<0.001),而 TB 患者的淋巴细胞比显著低于非 TB 患者(p<0.001)。抗结核治疗后 MMP9 和 STAT1 的表达下调。对于 STB,使用 6 个临床预测指标(MR、NR、LR、ESR、BMI 和 PLT)构建临床诊断模型。该模型的 ROC 曲线评估结果为 AUC=0.816。

结论

MMP9 和 STAT1 是与免疫相关的枢纽蛋白,与 STB 患者的免疫细胞浸润有关。MR、NR、LR、ESR、BMI 和 PLT 是 STB 的临床预测指标。因此,基于免疫细胞浸润的临床诊断模型可以有效地预测 STB。

相似文献

1
MMP9 and STAT1 are biomarkers of the change in immune infiltration after anti-tuberculosis therapy, and the immune status can identify patients with spinal tuberculosis.MMP9 和 STAT1 是抗结核治疗后免疫浸润变化的生物标志物,免疫状态可以识别脊柱结核患者。
Int Immunopharmacol. 2023 Mar;116:109588. doi: 10.1016/j.intimp.2022.109588. Epub 2023 Feb 9.
2
Mechanism of COVID-19-Related Proteins in Spinal Tuberculosis: Immune Dysregulation.COVID-19 相关蛋白在脊柱结核中的作用机制:免疫失调。
Front Immunol. 2022 Jun 2;13:882651. doi: 10.3389/fimmu.2022.882651. eCollection 2022.
3
A plasma 3-marker microRNA biosignature distinguishes spinal tuberculosis from other spinal destructive diseases and pulmonary tuberculosis.一种血浆 3 标志物 microRNA 生物标志物可区分脊柱结核与其他脊柱破坏性疾病和肺结核。
Front Cell Infect Microbiol. 2023 Feb 28;13:1125946. doi: 10.3389/fcimb.2023.1125946. eCollection 2023.
4
Expression and Clinical Significance of lncRNA NEAT1 in Patients with Spinal Tuberculosis.lncRNA NEAT1 在脊柱结核患者中的表达及临床意义。
Dis Markers. 2022 Apr 14;2022:5748756. doi: 10.1155/2022/5748756. eCollection 2022.
5
Identification of hub genes and establishment of a diagnostic model in tuberculosis infection.结核病感染中枢纽基因的鉴定及诊断模型的建立
AMB Express. 2024 Apr 13;14(1):36. doi: 10.1186/s13568-024-01691-7.
6
Comprehensive analysis of hub biomarkers associated with immune and oxidative stress in Hashimoto's thyroiditis.桥本甲状腺炎中与免疫和氧化应激相关的枢纽标志物的综合分析。
Arch Biochem Biophys. 2023 Sep 1;745:109713. doi: 10.1016/j.abb.2023.109713. Epub 2023 Aug 4.
7
Integrated Bioinformatics-Based Analysis of Hub Genes and the Mechanism of Immune Infiltration Associated With Acute Myocardial Infarction.基于综合生物信息学的急性心肌梗死相关枢纽基因及免疫浸润机制分析
Front Cardiovasc Med. 2022 Apr 6;9:831605. doi: 10.3389/fcvm.2022.831605. eCollection 2022.
8
Performance of conventional histopathology and GeneXpert MTB/RIF in the diagnosis of spinal tuberculosis from bone specimens: A prospective clinical study.常规组织病理学与 GeneXpert MTB/RIF 检测在骨标本诊断脊柱结核中的应用:一项前瞻性临床研究。
Clin Biochem. 2020 Nov;85:33-37. doi: 10.1016/j.clinbiochem.2020.08.010. Epub 2020 Aug 25.
9
Neutrophil-lymphocyte ratio as a potential marker for differential diagnosis between spinal tuberculosis and pyogenic spinal infection.中性粒细胞-淋巴细胞比值作为鉴别脊柱结核与化脓性脊柱感染的潜在标志物。
J Orthop Surg Res. 2022 Jul 21;17(1):357. doi: 10.1186/s13018-022-03250-x.
10
Identification of hub genes and their correlation with immune infiltration in coronary artery disease through bioinformatics and machine learning methods.通过生物信息学和机器学习方法鉴定冠心病中的枢纽基因及其与免疫浸润的相关性。
J Thorac Dis. 2022 Jul;14(7):2621-2634. doi: 10.21037/jtd-22-632.

引用本文的文献

1
Higher proportion of coagulative necrosis and PD-L1 immune cells in splenic tuberculosis.脾脏结核中凝固性坏死和程序性死亡受体配体1(PD-L1)免疫细胞的比例更高。
Sci Rep. 2025 Aug 26;15(1):31348. doi: 10.1038/s41598-025-15754-7.
2
Common diagnostic biomarkers and molecular mechanisms of infection and inflammatory bowel disease.感染与炎症性肠病的常见诊断生物标志物及分子机制
Front Immunol. 2024 Dec 5;15:1492810. doi: 10.3389/fimmu.2024.1492810. eCollection 2024.
3
Molecular Indicator for Distinguishing Multi-drug-Resistant Tuberculosis from Drug Sensitivity Tuberculosis and Potential Medications for Treatment.
区分耐多药结核病与药物敏感结核病的分子指标及潜在治疗药物
Mol Biotechnol. 2024 Oct 24. doi: 10.1007/s12033-024-01299-z.
4
Unlocking the Diagnostic Potential: A Systematic Review of Biomarkers in Spinal Tuberculosis.挖掘诊断潜力:脊柱结核生物标志物的系统评价
J Clin Med. 2024 Aug 25;13(17):5028. doi: 10.3390/jcm13175028.
5
USP9X inhibits metastasis in pulmonary sarcomatoid carcinoma by regulating epithelial-mesenchymal transition, angiogenesis and immune infiltration.USP9X通过调节上皮-间质转化、血管生成和免疫浸润来抑制肺肉瘤样癌的转移。
Transl Oncol. 2024 Sep;47:101950. doi: 10.1016/j.tranon.2024.101950. Epub 2024 Jul 3.
6
Prediction model for spinal cord injury in spinal tuberculosis patients using multiple machine learning algorithms: a multicentric study.基于多机器学习算法的脊柱结核患者脊髓损伤预测模型:一项多中心研究。
Sci Rep. 2024 Apr 2;14(1):7691. doi: 10.1038/s41598-024-56711-0.
7
ERK1/2-CEBPB Axis-Regulated hBD1 Enhances Anti-Tuberculosis Capacity in Alveolar Type II Epithelial Cells.ERK1/2-CEBPB 轴调控的 hBD1 增强肺泡 II 型上皮细胞的抗结核能力。
Int J Mol Sci. 2024 Feb 18;25(4):2408. doi: 10.3390/ijms25042408.
8
Single-cell RNA analysis to identify five cytokines signaling in immune-related genes for melanoma survival prognosis.单细胞 RNA 分析鉴定五种与免疫相关基因相关的细胞因子信号对黑色素瘤生存预后的影响。
Front Immunol. 2023 Mar 21;14:1148130. doi: 10.3389/fimmu.2023.1148130. eCollection 2023.